Digihaler-SF 250 Inhaler

babies: it is not applicable. lactating mother: it is safe during breastfeeding.
pregnancy: it is unsafe during pregnancy. limited studies have shown harmful effects on the developing baby.
please consult your doctor. driving: it is not applicable.
alcohol: information is not available on whether it is safe to consume alcohol with this medication. kidney: not applicable. liver: not applicable..

Nausea Headache Vomiting Respiratory tract infection Fungal infections in the mouth Sore throat Hoarseness of voice Cough Musculoskeletal pain Increased heart rate.

DIGIHALER SF inhaler is an bronchodilator and steroid. DIGIHALER SF xinafoate inhaler works by relaxing the muscles in the airways and widen the airways.
Fluticasone propionate inhaler works by stopping the release of chemical messenger that causes inflammation of the airways. Together they make breath easier.

If you miss a dose, Take it as soon as possible. If It is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• This medication is for inhalation purposes only • Take this medication at the same time each day • Take the first dose of This medicine under medical supervision as It may cause wheezing or tightening of the airways after using This medication • It does not work right away, then use your rescue inhaler to control your breathing problem • gargle with warm water after each inhalation to avoid any fungal infections in your mouth and throat • A dry mouth may occur as a side effect. To reduce This side effect, frequently wash your mouth, keep good oral, increased water intake, and sugarless Candy.

serious • fluticasone propionate + atazanavir: concurrent use leads to an increase in the level or effect of fluticasone intranasal by affecting hepatic/intestinal enzyme cyp3a4 metabolism • fluticasone propionate + clarithromycin: concurrent use leads to increase the level or effect of fluticasone intranasal by affecting hepatic/intestinal enzyme cyp3a4 metabolism • fluticasone propionate + conivaptan: concurrent use leads to increase the level or effect of fluticasone intranasal by affecting hepatic/intestinal enzyme cyp3a4 metabolism • salmeterol xinafoate + fosamprenavir: concurrent use leads to an increase in the level or effect of fluticasone intranasal by affecting hepatic/intestinal enzyme cyp3a4 metabolism monitor closely • salmeterol xinafoate + fedratinib: concurrent use leads to increase the level or effect of fluticasone intranasal by affecting hepatic/intestinal enzyme cyp3a4 metabolism • salmeterol xinafoate + letermovir: concurrent use leads to an increase in the level or effect of fluticasone intranasal by affecting hepatic/intestinal enzyme cyp3a4 metabolism.